Kusajili – Clinical trials directory

Result of your search per sponsor: Andrzej Jakubowiak, MD

Woman and Man Max 99 years
Andrzej Jakubowiak, MD Update Il y a 4 ans

Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma This study will be a multi-center, open-label, Phase 2 study where newly diagnosed Multiple Myeloma requiring systemic chemotherapy will be eligible for enrollment. A total of 55 subjects ...

Country None
organs None
Specialty None

Closed trial

More information